Furthermore, the TP53 mutation spectrum is likely tumor-specific (e.g., G>T transversions in lung cancer that do not correspond to the classic TP53 hotspot mutations) (Olive et al., 2004; Petitjean et al., 2007). This evidence concerns the gene TP53 and lung cancer.